274 related articles for article (PubMed ID: 8990061)
1. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
Tarsy D
Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
[TBL] [Abstract][Full Text] [Related]
2. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
Kaji R; Osawa M; Yanagisawa N
Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
[TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
6. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
[TBL] [Abstract][Full Text] [Related]
7. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Factor SA; Molho ES; Evans S; Feustel PJ
Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of botulinum toxin A for headache in cervical dystonia.
Ondo WG; Gollomp S; Galvez-Jimenez N
Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.
Odergren T; Tollbäck A; Borg J
Scand J Rehabil Med; 1994 Dec; 26(4):191-5. PubMed ID: 7878393
[TBL] [Abstract][Full Text] [Related]
12. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
Comella CL; Stebbins GT; Goetz CG; Chmura TA; Bressman SB; Lang AE
Mov Disord; 1997 Jul; 12(4):570-5. PubMed ID: 9251076
[TBL] [Abstract][Full Text] [Related]
13. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
Comella CL; Shannon KM; Jaglin J
Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
[TBL] [Abstract][Full Text] [Related]
14. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
15. Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
Espay AJ; Trosch R; Suarez G; Johnson J; Marchese D; Comella C
Parkinsonism Relat Disord; 2018 Jul; 52():94-97. PubMed ID: 29530726
[TBL] [Abstract][Full Text] [Related]
16. Excessive daytime sleepiness in cervical dystonia.
Trotti LM; Esper CD; Feustel PJ; Bliwise DL; Factor SA
Parkinsonism Relat Disord; 2009 Dec; 15(10):784-6. PubMed ID: 19447065
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cervical dystonia: a comparison of measures for outcome assessment.
Lindeboom R; Brans JW; Aramideh M; Speelman HD; De Haan RJ
Mov Disord; 1998 Jul; 13(4):706-12. PubMed ID: 9686779
[TBL] [Abstract][Full Text] [Related]
18. Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data.
Jen MH; Kurth H; Iheanacho I; Dinet J; Gabriel S; Wasiak R; Jost WH
J Med Econ; 2014 Nov; 17(11):803-9. PubMed ID: 25155368
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia.
Hung SW; Hamani C; Lozano AM; Poon YY; Piboolnurak P; Miyasaki JM; Lang AE; Dostrovsky JO; Hutchison WD; Moro E
Neurology; 2007 Feb; 68(6):457-9. PubMed ID: 17283323
[TBL] [Abstract][Full Text] [Related]
20. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
Dressler D; Kupsch A; Seitzinger A; Paus S
Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
